Modern medicines series SGLT2 Inhibitors: Webinar 2 - SGLT2 inhibitors and the heart
Professor Cliff Bailey and Dr Martin Hadley-Brown discuss the effects of SGLT2 inhibitors on cardiovascular function and their role in the management of CV disease, specifically: Cardiovascular disease in type 2 diabetes; SGLT2 inhibitors lower blood pressure; SGLT2 inhibitors reduced heart failure risk; Mechanisms of SGLT2 inhibitors on heart and circulation; Improve BP control independently of other antihypertensives; Reduce risk of new onset or worsening heart failure; May benefit atherosclerotic cardiovascular disease; Positioned in algorithms for type 2 diabetes by CV effects.
Download the factsheet to this webinar below or watch the on-demand video here:
View the on-demand webinar
And don't forget to complete the CPD programme on our Sister site BJPCN to get your CPD points and download your certificate:
Go to the CPD programme*